Literature DB >> 25432121

Global burden of atrial fibrillation in developed and developing nations.

Sumeet S Chugh1, Gregory A Roth2, Richard F Gillum3, George A Mensah4.   

Abstract

Atrial fibrillation is the most common heart rhythm disorder in the world, with major public health impact especially due to increased risk of stroke and hospitalizations. The recently published results on epidemiology of atrial fibrillation from the Global Burden of Diseases, Injuries, and Risk Factors Study confirm the existence of a significant and progressive worldwide increase in the burden of atrial fibrillation. However, there appears to be regional variation in both the burden of atrial fibrillation and availability of epidemiological data regarding this condition. In this review, the authors identify issues that are unique to the developed versus developing regions and outline a road map for possible approaches to surveillance, management, and prevention of atrial fibrillation at the global level.
Copyright © 2014 World Heart Federation (Geneva). All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25432121     DOI: 10.1016/j.gheart.2014.01.004

Source DB:  PubMed          Journal:  Glob Heart        ISSN: 2211-8160


  58 in total

Review 1.  Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review.

Authors:  Boris Arbit; Jonathan C Hsu
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

2.  Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.

Authors:  Letícia C Tavares; Nubia E Duarte; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo Caleb Junior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2018-07-26       Impact factor: 2.953

3.  The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey.

Authors:  Giuseppe Mulè'; Caterina Carollo; Marco Guarneri; Santina Cottone
Journal:  Intern Emerg Med       Date:  2018-08-16       Impact factor: 3.397

4.  Phase synchrony reveals organization in human atrial fibrillation.

Authors:  David Vidmar; Sanjiv M Narayan; Wouter-Jan Rappel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 5.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 6.  Cardiac arrhythmias in low- and middle-income countries.

Authors:  Philasande Mkoko; Ehete Bahiru; Olujimi A Ajijola; Aime Bonny; Ashley Chin
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

7.  Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study.

Authors:  Apurv Soni; Sunil Karna; Nisha Fahey; Saket Sanghai; Harshil Patel; Shyamsundar Raithatha; Sunil Thanvi; Somashekhar Nimbalkar; Ben Freedman; Jeroan Allison; David D McManus
Journal:  Int J Cardiol       Date:  2018-12-06       Impact factor: 4.164

8.  Genetically Determined Birthweight Associates With Atrial Fibrillation: A Mendelian Randomization Study.

Authors:  Rachel L Kember; Michael G Levin; Diana L Cousminer; Noah Tsao; Renae Judy; Gayatri M Schur; Steven A Lubitz; Patrick T Ellinor; Shana E McCormack; Struan F A Grant; Daniel J Rader; Benjamin F Voight; Scott M Damrauer
Journal:  Circ Genom Precis Med       Date:  2020-04-27

Review 9.  Antiplatelet Therapy During PCI for Patients with Stable Angina and Atrial Fibrillation.

Authors:  Amjid Iqbal; Fatima Rodriguez; Henrik Schirmer
Journal:  Curr Cardiol Rep       Date:  2015-08       Impact factor: 2.931

10.  Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  Clin Cardiol       Date:  2018-10-02       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.